<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Phys.org: Phys.Org news tagged with: pancreatic cancer</title>
<link>http://phys.org/</link>
<language>en-us</language> 
<description>Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine.</description>

 <item>
     <title>Predicting prognosis and treatment response in a subset of pancreatic cancer patients</title>
   	 <description>Specific chemical modifications to proteins called histones, which are found in the nucleus of cells and act as spools around which DNA is wound, can be used to predict prognosis and response to treatment in subsets patients with pancreatic cancer, a study by researchers at UCLA's Jonsson Comprehensive Cancer Center has found.</description>
     <link>http://phys.org/news185104379.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 11 Feb 2010 10:10:01 EST</pubDate>
	 <guid isPermaLink="false">news185104379</guid>
	 
</item>
<item>
     <title>Soft drink consumption may increase risk of pancreatic cancer</title>
   	 <description>Consuming two or more soft drinks per week increased the risk of developing pancreatic cancer by nearly twofold compared to individuals who did not consume soft drinks, according to a report in Cancer Epidemiology, Biomarkers &amp; Prevention, a journal of the American Association for Cancer Research.</description>
     <link>http://phys.org/news184828475.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 08 Feb 2010 05:30:02 EST</pubDate>
	 <guid isPermaLink="false">news184828475</guid>
	 
</item>
<item>
     <title>Scientists show how molecular switch helps pancreatic cancer beat drugs</title>
   	 <description>Researchers at the Moores Cancer Center at the University of California, San Diego, have found one reason that pancreatic cancer tumors are so difficult to treat with drugs. They have shown how a molecular switch steps up pancreatic cancer cell survival as well as resistance to a standard chemotherapy drug, and have identified alternate routes cancer cells take to avoid the effects of the therapy.</description>
     <link>http://phys.org/news183924018.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 28 Jan 2010 18:20:01 EST</pubDate>
	 <guid isPermaLink="false">news183924018</guid>
	 
</item>
<item>
     <title>Having a family member under 50 diagnosed with pancreatic cancer increases risk</title>
   	 <description>A person who has multiple family members with pancreatic cancer (&quot;familial pancreatic cancer&quot;) is six times as likely to develop that cancer. This risk is even higher, nine times that of the general population, if one of their relatives developed their cancer under the age of 50, according to a new study published online January 12 in the Journal of the National Cancer Institute.</description>
     <link>http://phys.org/news182582259.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 13 Jan 2010 06:00:01 EST</pubDate>
	 <guid isPermaLink="false">news182582259</guid>
	 
</item>
<item>
     <title>Pancreatic tumors are marked for immunotherapy</title>
   	 <description>Pancreatic tumors can be identified by a readily detectable marker that shows promise as a basis for immune therapy against the disease, according to research at Washington University School of Medicine in St. Louis.</description>
     <link>http://phys.org/news178823918.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 30 Nov 2009 17:30:02 EST</pubDate>
	 <guid isPermaLink="false">news178823918</guid>
	 
</item>
<item>
     <title>Is type 2 diabetes mellitus a risk factor for gallbladder, biliary and pancreatic cancer?</title>
   	 <description>There are minimal data assessing the relationship between diabetes with gallbladder, biliary and pancreatic cancer. Recent small studies have suggested an elevated risk of pancreatic cancer only in patients with diabetes mellitus (DM).</description>
     <link>http://phys.org/news177851081.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 19 Nov 2009 11:40:01 EST</pubDate>
	 <guid isPermaLink="false">news177851081</guid>
	 
</item>
<item>
     <title>Discovery offers potential new pancreatic cancer treatment</title>
   	 <description>Tiny particles that can carry drugs and target cancer cells may offer treatment hope for those suffering with pancreatic cancer.  New research to be presented in November at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting in Los Angeles reveals that tumor-penetrating microparticles (TPM) have been specifically designed to break through hard-to-infiltrate barriers and deliver drugs more effectively and efficiently than the standard form of chemotherapy such as those injected through a vein.</description>
     <link>http://phys.org/news176392083.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 02 Nov 2009 14:20:01 EST</pubDate>
	 <guid isPermaLink="false">news176392083</guid>
	 
</item>
<item>
     <title>Possible origins of pancreatic cancer revealed</title>
   	 <description>(PhysOrg.com) -- MIT cancer biologists have identified a subpopulation of cells that can give rise to pancreatic cancer. They also found that tumors can form in other, more mature pancreatic cell types, but only when they are injured or inflamed, suggesting that pancreatic cancer can arise from different types of cells depending on the circumstances.</description>
     <link>http://phys.org/news176386790.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 02 Nov 2009 12:20:27 EST</pubDate>
	 <guid isPermaLink="false">news176386790</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/possibleorig.jpg" width="90" height="67" />
</item>
<item>
     <title>Hepatitis B does not increase risk for pancreatic cancer</title>
   	 <description>A Henry Ford Hospital study found that hepatitis B does not increase the risk for pancreatic cancer - and that only age is a contributing factor.</description>
     <link>http://phys.org/news176266146.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 01 Nov 2009 02:49:33 EST</pubDate>
	 <guid isPermaLink="false">news176266146</guid>
	 
</item>
<item>
     <title>Circulating Mesothelin Serves as a Marker of Pancreatic Cancer</title>
   	 <description>(PhysOrg.com) -- Researchers have expanded on previous studies, and there may be a new weapon in the arsenal for immune-based strategies in treating pancreatic cancer - mesothelin protein. Findings also showed that circulating mesothelin is a marker of pancreatic disease.</description>
     <link>http://phys.org/news175447210.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 22 Oct 2009 17:00:02 EST</pubDate>
	 <guid isPermaLink="false">news175447210</guid>
	 
</item>
<item>
     <title>Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy</title>
   	 <description>For the first time researchers have shown that by inhibiting the action of an enzyme called TAK-1, it is possible to make pancreatic cancer cells sensitive to chemotherapy, opening the way for the development of a new drug to treat the disease.</description>
     <link>http://phys.org/news172992288.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 24 Sep 2009 06:40:01 EST</pubDate>
	 <guid isPermaLink="false">news172992288</guid>
	 
</item>
<item>
     <title>Endothelin-1 inhibitors in chronic pancreatitis</title>
   	 <description>Fibrosis is a key feature of chronic pancreatitis and pancreatic cancer. The extensive deposition of extracellular matrix proteins fosters the development of an exocrine and endocrine organ insufficiency, and accelerates progression of the tumour. Pancreatic stellate cells (PSC) are the principal effector cells in pancreatic fibrosis. They are activated by profibrogenic mediators, which include, for example, cytokines and ethanol metabolites. So far, there are no therapies available to interfere with fibrogenesis in the diseased organ.</description>
     <link>http://phys.org/news172397446.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 17 Sep 2009 09:12:01 EST</pubDate>
	 <guid isPermaLink="false">news172397446</guid>
	 
</item>
<item>
     <title>Malignant signature may help identify patients likely to respond to therapy</title>
   	 <description>A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies, will be published September 6 in the advance online edition of Nature Medicine.</description>
     <link>http://phys.org/news171462152.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sun, 06 Sep 2009 13:23:38 EST</pubDate>
	 <guid isPermaLink="false">news171462152</guid>
	 
</item>
<item>
     <title>Pancreatic cancer affects blacks at higher rates</title>
   	 <description>Regardless of risk factors linked to pancreatic cancer, such as smoking and body mass index (BMI), blacks experienced higher rates of pancreatic cancer death than whites.</description>
     <link>http://phys.org/news171031591.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 01 Sep 2009 14:00:01 EST</pubDate>
	 <guid isPermaLink="false">news171031591</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/pancreaticca.jpg" width="90" height="96" />
</item>
<item>
     <title>Does the distance a patient has to travel affect where they choose to get their care?</title>
   	 <description>Do patients choose where to get their care based on how long it takes to them to get there?  Researchers at Fox Chase Cancer Center have recently documented a growing trend in the centralization of cancer surgery—more patients seeking care at high volume centers, which are generally located in metropolitan areas.  While trends like this should improve patient outcomes, a study published in the Journal of Clinical Oncology shows that there are still a good number of patients who will not travel a long distance to get their care.</description>
     <link>http://phys.org/news170960897.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 31 Aug 2009 18:40:04 EST</pubDate>
	 <guid isPermaLink="false">news170960897</guid>
	 
</item>
<item>
     <title>New initiative to develop modeling tools for disease and complex systems</title>
   	 <description>A multidisciplinary team led by Carnegie Mellon University computer scientist Edmund M. Clarke has received a five-year, $10 million grant from the National Science Foundation's Expeditions in Computing program to create revolutionary computational tools that will advance science on a broad array of fronts, from discovering new cancer treatments to designing safer aircraft.</description>
     <link>http://phys.org/news169890411.html</link>
	 <category>Technology</category>
	 <pubDate>Wed, 19 Aug 2009 09:00:04 EST</pubDate>
	 <guid isPermaLink="false">news169890411</guid>
	 
</item>
<item>
     <title>Prion protein identified as a novel early pancreatic cancer biomarker</title>
   	 <description>Mad cow disease is caused by the accumulation of an abnormal protein, the prion, in the brain of an affected patient. Outside of the brain, very little is known about prions. Case Western Reserve University School of Medicine, researchers have, for the first time, identified the prion as a biomarker for pancreatic cancer. Pancreatic cancer is one of the most deadly cancers in humans; the five year survival rate is less than 10 percent.</description>
     <link>http://phys.org/news169751882.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 17 Aug 2009 22:50:01 EST</pubDate>
	 <guid isPermaLink="false">news169751882</guid>
	 
</item>
<item>
     <title>New study expands the list of hazardous chemicals in smokeless tobacco</title>
   	 <description>Attention all smokeless tobacco users!  It's time to banish the comforting notion that snuff and chewing tobacco are safe because they don't burn and produce inhalable smoke like cigarettes. A study that looked beyond the well-researched tobacco hazards, nitrosamines and nicotine, has discovered a single pinch -- the amount in a portion -- of smokeless tobacco exposes the user to the same amount of another group of dangerous chemicals as the smoke of five cigarettes.</description>
     <link>http://phys.org/news169644304.html</link>
	 <category>Chemistry</category>
	 <pubDate>Sun, 16 Aug 2009 12:40:01 EST</pubDate>
	 <guid isPermaLink="false">news169644304</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/1-newstudyexpa.jpg" width="90" height="67" />
</item>
<item>
     <title>New tool may help with early detection of deadly pancreatic cancer</title>
   	 <description>A new diagnostic tool developed by Van Andel Research Institute (VARI) scientists has shown promising results when used with patients of pancreatic cancer, one of the deadliest forms of cancer due to the difficulty of diagnosing it in its early stages. The method, which studies carbohydrate structures in the bloodstream, could lead to the development of blood tests that can detect cancer more effectively.</description>
     <link>http://phys.org/news168526022.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 03 Aug 2009 14:00:02 EST</pubDate>
	 <guid isPermaLink="false">news168526022</guid>
	 
</item>
<item>
     <title>Common diabetic therapy reduces risk of pancreatic cancer, study finds</title>
   	 <description>Taking the most commonly-prescribed anti-diabetic drug, metformin, reduces an individual's risk of developing pancreatic cancer by 62 percent, according to research from The University of Texas M. D. Anderson Cancer Center, published in the Aug. 1 issue of Gastroenterology.</description>
     <link>http://phys.org/news168324813.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Sat, 01 Aug 2009 09:00:01 EST</pubDate>
	 <guid isPermaLink="false">news168324813</guid>
	 <media:thumbnail url="http://cdn.physorg.com/newman/gfx/news/tmb/2009/1-mdandersonst.jpg" width="90" height="135" />
</item>
<item>
     <title>Smoking increases potential for metastatic pancreatic cancer</title>
   	 <description>Smoking has once again been implicated in the development of advanced cancer. Exposure to nicotine by way of cigarette smoking may increase the likelihood that pancreatic ductal adenocarcinoma will become metastatic, according to researchers from the Kimmel Cancer Center at Jefferson. Their study was published in the August edition of the journal Surgery.</description>
     <link>http://phys.org/news167922110.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 27 Jul 2009 14:30:02 EST</pubDate>
	 <guid isPermaLink="false">news167922110</guid>
	 
</item>
<item>
     <title>New drug candidate prolongs the lives of pancreatic cancer patients</title>
   	 <description>Every year, 42,000 Americans are diagnosed with pancreatic cancer. Few live very long, and less than 5% are still alive five years after diagnosis.</description>
     <link>http://phys.org/news167310392.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 20 Jul 2009 12:30:01 EST</pubDate>
	 <guid isPermaLink="false">news167310392</guid>
	 
</item>
<item>
     <title>Enhancement of pancreatic cancer on dynamic CT:  Does it correlate with angiogenesis and fibrosis?</title>
   	 <description>Prognosis of pancreatic cancer is poor. Recently, it has been clarified that the grade of tumor angiogenesis is a useful prognostic marker in human cancer, including pancreatic cancer. To establish the grade of tumor angiogenesis by non-invasive imaging may be important clinically. However, there are only a few such reports on pancreatic cancer.</description>
     <link>http://phys.org/news166968779.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 16 Jul 2009 13:17:44 EST</pubDate>
	 <guid isPermaLink="false">news166968779</guid>
	 
</item>
<item>
     <title>Dietary fat linked to pancreatic cancer</title>
   	 <description>High intake of dietary fats from red meat and dairy products was associated with an increased risk of pancreatic cancer, according to a new study published online June 26 in the Journal of the National Cancer Institute.</description>
     <link>http://phys.org/news165255064.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Fri, 26 Jun 2009 17:11:34 EST</pubDate>
	 <guid isPermaLink="false">news165255064</guid>
	 
</item>
<item>
     <title>Study finds strong relationship between high body mass index, pancreatic cancer</title>
   	 <description>In reviewing the weight history of pancreatic cancer patients across their life spans, researchers at The University of Texas M. D. Anderson Cancer Center have determined that a high body mass index in early adulthood may play a significant role in an individual developing the disease at an earlier age.</description>
     <link>http://phys.org/news164994503.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 23 Jun 2009 16:49:15 EST</pubDate>
	 <guid isPermaLink="false">news164994503</guid>
	 
</item>
<item>
     <title>Adenoviral vector specifically targeted to EphA2 receptor in pancreatic cancer cells</title>
   	 <description>Pancreatic cancer is a devastating disease with poor prognosis. This warrants the development of novel therapies including gene therapy. However, clinical studies have demonstrated poor efficacy of adenoviral gene therapy because of the absence of adenoviral binding sites on pancreatic cancer cells such as the coxsackie and adenovirus receptor (CAR). Circumventing CAR-mediated entry therefore seems a promising option to improve adenoviral entry into pancreatic cancer cells and to enhance the efficacy of adenoviral vectors.</description>
     <link>http://phys.org/news164977499.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Tue, 23 Jun 2009 12:06:32 EST</pubDate>
	 <guid isPermaLink="false">news164977499</guid>
	 
</item>
<item>
     <title>Variability in pancreatic cancer care found with newly developed quality indicators</title>
   	 <description>A set of expert consensus-based, quality-of-care indicators identified considerable variability in the quality of pancreatic cancer care among hospitals and may be used to evaluate and identify areas for improvement, according to a new study in the June 9 online issue of the Journal of the National Cancer Institute.</description>
     <link>http://phys.org/news163822485.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Wed, 10 Jun 2009 03:15:36 EST</pubDate>
	 <guid isPermaLink="false">news163822485</guid>
	 
</item>
<item>
     <title>Researchers identify critical marker of response to gemcitabine in pancreatic cancer</title>
   	 <description>A protein related to aggressive cancers can actually improve the efficacy of gemcitabine at treating pancreatic cancer, according to a Priority Report in Cancer Research, published by researchers at Thomas Jefferson University.</description>
     <link>http://phys.org/news163331753.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 04 Jun 2009 10:56:19 EST</pubDate>
	 <guid isPermaLink="false">news163331753</guid>
	 
</item>
<item>
     <title>New pathology tests double sensitivity to detect bile duct and pancreatic cancers</title>
   	 <description>Pancreatic cancer and bile duct cancer are difficult to diagnose and often fatal because they are discovered in the advanced stages of the disease. Researchers have developed new tests that double the ability to detect bile duct and pancreatic cancers, according to a Mayo Clinic study published in the June issue of Gastroenterology.</description>
     <link>http://phys.org/news163061370.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Mon, 01 Jun 2009 07:49:53 EST</pubDate>
	 <guid isPermaLink="false">news163061370</guid>
	 
</item>
<item>
     <title>Popular diabetes treatment could trigger pancreatitis, pancreatic cancer</title>
   	 <description>A drug widely used to treat Type 2 diabetes may have unintended effects on the pancreas that could lead to a form of low-grade pancreatitis in some patients and a greater risk of pancreatic cancer in long-term users, UCLA researchers have found. </description>
     <link>http://phys.org/news160326333.html</link>
	 <category>Medicine &amp; Health</category>
	 <pubDate>Thu, 30 Apr 2009 16:05:54 EST</pubDate>
	 <guid isPermaLink="false">news160326333</guid>
	 
</item>


</channel>
</rss>
